Catheter Precision, Inc. (VTAK)

Market Cap	2.92M
Revenue (ttm)	481,000
Net Income (ttm)	-23.17M
Shares Out	12.59M
EPS (ttm)	-3.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,761,567
Open	0.2284
Previous Close	0.2420
Day's Range	0.2223 - 0.2410
52-Week Range	0.1648 - 8.4000
Beta	-0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2025

About VTAK

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also offers LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 30, 2018
• Employees: 22
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: VTAK
• Website: https://www.catheterprecision.com

Financial Performance

In 2024, Catheter Precision's revenue was $420,000, a decrease of -4.98% compared to the previous year's $442,000. Losses were -$21.80 million, -69.45% less than in 2023.